Skip to main content

Find Clinical Trials

Home
Conditions
Skin Diseases

Clinical trial condition

Skin Diseases

Explore clinical trials studying Skin Diseases. Study availability and eligibility vary by location and protocol.

23,025 public trials 3,714 recruiting studies

Refine in advanced search Browse all conditions

Skin Diseases trial results

Recruiting

Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations

NCT07739121

Conditions: Artifical Intelligence, Breast Diseases, Breast Neoplasms, +31 more
Locations: Hopital Européen Georges Pompidou Paris, France

View Trial Details

Recruiting

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT07288359

Conditions: Advanced CCNE1-amplified Solid Tumors, Advanced HR+/HER2- Breast Cancer, Breast Diseases, +14 more
Locations: Tennessee Oncology PLLC Nashville, Tennessee, United States

START San Antonio, Texas, United States

Novartis Investigative Site Olomouc, Czechia

Novartis Investigative Site Odense C, Denmark

View all 15 locations

View Trial Details

Recruiting

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

NCT06947460

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +17 more
Locations: 北京高博医院 Beijing, China,Beijing, China

View Trial Details

Recruiting

Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function

NCT06943469

Conditions: Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: AZ Sint-Jan Brugge-Oostende AV - Campus Sint-Jan Bruges, Belgium

Universitair Ziekenhuis Brussel - Kinderziekenhuis Brussels, Belgium

Clinique Ste Elisabeth Namur, Belgium

CHU Amiens Picardie Amiens, France

View all 25 locations

View Trial Details

Recruiting

Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery

NCT07686250

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

NCT07285044

Conditions: Adenocarcinoma, Adnexal Diseases, Amyloidosis, +130 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC)

NCT06959537

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Intra-operative Detection of Positive Margins and Lymph Nodes in Breast Surgery

NCT06977698

Conditions: Breast Cancer Invasive, Breast Diseases, Breast Neoplasms, +7 more
Locations: Nottingham university hospitals Nottingham, United Kingdom

View Trial Details

Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

NCT05267626

Conditions: Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +57 more
Locations: Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States

START Midwest Grand Rapids, Michigan, United States

Minnesota Oncology and Hematology PA Minneapolis, Minnesota, United States

Washington University St Louis, Missouri, United States

View all 18 locations

View Trial Details

Recruiting

Study of Ravulizumab in Pediatric Participants With Primary IgAN

NCT07024563

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Cardiovascular Diseases, +36 more
Locations: Research Site Palo Alto, California, United States

Research Site Aurora, Colorado, United States

Research Site Beijing, China

Research Site Shanghai, China

View all 15 locations

View Trial Details